ÂÜÀòÂÒÂ×

Dr. Aleksander S. Popel is also a Professor of Biomedical Engineering, Medicine, and Oncology at the Johns Hopkins University School of Medicine. He is a member of the Sidney Kimmel Comprehensive Cancer Center. His areas of expertise are angiogenesis and lymphangiogenesis, immuno-oncology, systems biology, systems pharmacology, and discovery and development of peptide therapeutic agents. He published over 340 scientific papers in these areas; he also holds over 30 issued and pending patents on the peptides and their delivery. He received his Ph.D. in Biofluid Mechanics from Moscow University. He served as a Visiting Professor at MIT, Harvard University, and Imperial College, U.K. He is a recipient of the Eugene M. Landis Award from the Microcirculatory Society, the highest award bestowed by the Society. He delivered keynote addresses for The Virtual Physiological Human (VPH) European Union Physiome Project and Next-Generation Integrated Simulation of Living Matter Project in Japan; he was C. Forbes Dewey Distinguished Lecturer in Biological Engineering at the Massachusetts Institute of Technology, delivered A.C. Suhren Lecture at Tulane University, Robert M. and Mary Haythornthwaite Distinguished Lecturer at Temple University, and Kawasaki Medical Society Lecturer in Japan. Dr. Popel mentored over 70 graduate students and postdoctoral fellows; many of his trainees are leaders in the field of biomedical engineering and systems biology in academia and pharmaceutical industry. He is a Fellow of the American Institute of Medical and Biological Engineering, American Heart Association, American Physiological Society, and American Society of Mechanical Engineers, and an Inaugural Fellow of the Biomedical Engineering Society. He has been a member of editorial boards of leading biological and biomedical engineering journals. He served in an advisory role to biotech and pharmaceutical companies. He has served on grant review boards and advisory panels at the National Institutes of Health, National Science Foundation, and other US and international funding agencies. His work at the Johns Hopkins University has been supported by grants from the National Institutes of Health, the Safeway Breast Cancer Foundation, the Maryland Technology Development Corporation, Department of Defense, the Coulter Foundation Translational Partnership, the Edward N. and Della L. Thome Memorial Foundation Award in Age-Related Macular Degeneration Research, and pharmaceutical companies.